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A well-established expression of cell-mediated immunity has been separated 
from classical tuberculin type delayed hypersensitivity. Originally called "Jones 
Mote" sensitivity (1), it has been renamed cutaneous basophil hypersensitivity 
(CBH) (2) to emphasize the large numbers of basophilic leukocytes  that infiltrate 
the dermis in the skin lesions. Both conditions can be distinguished as well by 
differences in  immunogenic (3)  and tolerogenic (4)  requirements, as  well  as 
persistence of sensitivity. 
Both expressions of  cell-mediated, delayed-in-onset  type hypersensitivity  reac- 
tions (DH and CBH) have been thought to be mediated by sensitized thymus- 
derived (T) lymphocytes, but recent studies implicate antigen specific B cells as 
either effectors of CBH  (5)  or view CBH  as  a  product of a  classical delayed 
reaction modified by suppressor B cells (6). 
To further investigate the role of T and B cells in the mediation of CBH,  we 
took advantage of artificial antigens,  the response to which is  known to be 
controlled  by  histocompatibility-linked immune  response  genes  (7). In  the 
guinea pig, the development of delayed hypersensitivity as well as the produc- 
tion of antibody to the synthetic polymers poly-L-lysine (PLL), poly-L-glutamic- 
lysine (GL), and their dinitrophenylated (DNP) derivatives has been shown to 
be a  Mendelian dominant trait governed by a  single gene (8). Strain 2 and a 
fraction of outbred (responder) Hartley guinea pigs have the capacity to respond 
to these antigens, whereas strain 13 animals and nonresponder Hartleys do not. 
Nevertheless, genetically nonresponder animals have the capacity to produce 
antibody to DNP-PLL when this is complexed to an immunogenic carrier, thus 
indicating that their B cells do indeed recognize the hapten, whenever this is 
bound to a carrier molecule that is amenable to T-cell recognition (9). 
These findings lend support to the contention that the phenotypic expression 
of responder status must reside, at least operationally, in T cells. 
In this paper we present evidence that control of the development of CBH is 
also  linked  to  the  same  histocompatibility genes,  thus  indicating that  this 
reaction also operates through antigen-specific effector T cells.  We sensitized 
responder and nonresponder Hartley guinea pigs with DNP-GL in incomplete 
Freund's Adjuvant (IFA)  and tested them for the appearance of CBH.  Then 
shortly thereafter we checked their ability to produce delayed hypersensitivity 
to noncross-reacting DNP-PLL given in complete Freund's Adjuvant (CFA). 
Typical  CBH  and  DH  were obtained in  responder animals,  whereas nonre- 
sponders failed to give positive reactions of either type. 
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Materials and Methods 
Animals.  Female  Hartley  PLL  responder and nonresponder guinea pigs,  300 g,  were pur- 
chased from Carom Research Institute, Wayne, N. J. 
Antigens.  PLL, Mol Wt 40,000, was obtained from Sigma Chemical Company, St. Louis, Mo. 
A random linear copolymer ofGL, Mol Wt 40,000, in the proportions of 60:40 was a kind gift of Dr. 
B.  Benacerraf.  2,4-dinitrobenzenesulfonic acid,  sodium  salt (DNP  SOaH),  was purchased  from 
Eastman Organic Chemicals, Rochester, New York. 
Dinitrophenylation  of PLL and GL.  The method indicated by Williams and Chase (10)  was 
employed. Briefly, 50 mg of PLL, 50 mg of K~C03, and 14 mg ofDNP SO~H were dissolved in 3.2 ml 
of distilled water and stirred for 1 h, shielded from light with aluminum foil. The solution was then 
dialysed for several days against multiple changes of water and read in a spectrophotometer at 360 
nm. The degree of dinitrophenylation of the polymer was calculated to be 7.6 mol of DNP per PLL, 
using the molar absorbancy of DNP-lysine at 360 nm of 17,530.  To prepare DNP-GL  identical 
proportions 0fthe reagents were used, but the reaction was allowed to continue overnight. 5 mol of 
DNP per tool of GL was calculated employing the same method. 
Immunization and Skin Tests 
FoR CBH.  Groups of three responder and nonresponder guinea pigs were immunized in the foot 
pads with 100 and 10 ~g of DNP-GL in IFA.  1 wk later the animals were shaved and depilated on 
one flank and skin tested with 1,  10,  and 100/zg of DNP-GL in 0.1 ml of saline.  Gross reactions 
were read 24 h  thereafter, and the erythema was measured in millimeters. 
FoR DH.  All animals previously tested for CBH plus two normal controls were immunized 1 
day later with 100 ~g of DNP-PLL  in CFA in the foot pads.  3 wk later they were shaved and 
depilated on the opposite flanks and were skin tested with 1/~g DNP-PLL in 0.1 ml of saline, since 
larger doses gave local irritation and necrosis. Gross reactions were read and again 24 h thereaf- 
ter, and the degree of induration and erythema was measured in millimeters. 
Biopsies  and Histology.  Skin sites tested with DNP-GL  and  DNP-PLL  were  biopsied  with 
sterile instruments under anesthesia with ether. The wounds were sealed with 9-ram "autoclips" 
(Clay Adams, Inc., Parippany, N. J.) and wiped with 70% ethanol. The biopsies were cut in pieces 
of no  more  than  l-ram  thickness  with  a  razor  blade  on  a  plate  of dental  wax  and  fixed  in 
glutaraldehyde-paraformaldehyde for 5 h. Then they were placed in 0.1 M cacodylate buffer until 
postfixed in 2% OsO4,  dehydrated, and embedded in Epon.  1-~m sections were cut with a  Porter- 
Blum MT 1 microtome and stained with 10% Giemsa in 2% sodium borate. 
Sections were observed under oil with a light microscope with the aid of an ocular micrometer. 
Total cellularity and the percentage basephils in the upper dermis were calculated as reported 
before (11). 
Results 
CBH to DNP-GL. 
GROSS REACTIONS.  As  can  be  seen in Table  I,  typical erythematous, but 
nonindurated,  CBH reactions  were obtained  at 24  h  in all but one responder 
animal, but none of the nonresponder animals.  There was little difference in 
skin reactivity in animals immunized with 10 pg or 100 pg of antigen. Largest 
reactions were seen with a skin test dose of 100 fig DNP-GL, and these averaged 
about 25 mm of erythema. 
HISTOLOGY.  The cellular composition of the skin sites can be seen in Table II, 
where values are expressed as means of cell counts with standard errors. It is 
apparent that there is a considerable difference between responder and nonre- 
spender  animals  in  terms  of percentage  basophils  and  also,  but  to  a  lesser 
degree, in total cellularity. In responder animals the microscopic picture was in 
all cases that of a typical CBH (12). As has been usual in CBH, the best reactions 
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TABLE  I 
Cutaneous Basophil  Hypersensitivity  and Delayed Hypersensitivity  Reactions to Synthetic 




CBH to DNP -  GL 
Immuniz-  Adjuvant  Number 
ing  dose  used  animal 
Pg 
100  IFA  2 
1 
10  IFA  3 
I00  IFA  2 
10  IFA  3 
Average reaction to skin 
test with: 
100/~g  10 #zg  I p,g 
29*-*  11-  0- 
0-  0-  0- 
22-  20-  7- 
0-  0-  0- 
0-  0-  0- 
* Millimeter of erythema. 
$ Degree of induration:  -,  none;  +, marked. 
DH to DNP -  PLL 
Immuniz-  Adjuvant  Number 
ing  dose  used  animal 
#g 
I00  CFA  5 
1 
100  CFA  1 
100  CFA  5 











Cellular  Composition  of CBH and DH ReactiOns to Synthetic Polymers in Responder and 
Nonresponder Guinea Pigs 
Status  Antigen and 
adjuvant 
R  DNP-GL/IFA 
R  DNP-GL/IFA 
R  DNP-GL/IFA 
R  DNP-GL/IFA 
NR  DNP-GL/IFA 
NR  DNP-GL/IFA 
NR  DNP-GL/IFA 
NR  DNP-GL/IFA 
R  DNP-PLL/CFA 
NR  DNP-PLL/CFA 
Dose used for: 
Im  .~uniz- I Skin test- 
mg  1  mg 
~g 
100  10 
100  100 
10  10 
10  100 
100  10 
100  100 
10  10 
10  100 
I00  1 
100  1 
Number  Total cellu- 
animals  larity 
2  162  ±  1.5" 
2  157 ±  1.0 
3  148 _+  15.7 
3  232 ±  25.1 
2  156 ±  16 
2  126 _+ 4.5 
3  121 _+  15 
3  150_+  19 
1  359 
1  122 
Cells in upper dermis 
I 
M  B  N  E  1  MC 
I 
%  %  %  %  % 
75  16 ± 12.5  1.5  4.5  4 
71  28 ± 8.5  <1  2  <i 
68  25 ± 8.9  1  2.7  3 
52  42 ±  8.9  <1  <1  4.7 
85  2 -+  1.0  7  2  4.5 
90  3.5 ±  0.5  3  <1  3 
98  1.3  +  0.9  <1  <1  <1 
91  5 ±  1.0  <1  2.3  1.7 
91  2  2  1  4 
92  1  8  <1  <1 
R, responders; NR, nonre~ 
* Means +_ S.E. 
*onder;  M,  mononuclear  cells;  B,  basophils;  N,  neutrophils;  E,  eosinophils;  MC, mast  cells. 
and skin tested with larger (100 ~g) doses of antigen, but significant reactions 
were obtained in all other instances as well. Mean basophil counts in responder 
animals  immunized  with  IFA  varied  from  16-42%,  while  similarly  treated 
nonresponders never showed more than 5% basophils. No significant differences 
were detected in the number of eosinophils, neutrophils, and mast cells between 
both groups. 
DH to DNP-PLL 
GROSS REACTIONS.  Gross reactions to 1 /~g of DNP-PLL were erythematous 
and indurated in retested and control responder animals, as can be seen in Table 
I. One of the animals in this group that failed to give a positive CBH skin test to 
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therefore  considered to be a  nonresponder. Retested and control  nonresponder 
animals always gave negative skin tests. 
HISTOLOGY.  Table II shows for comparison that the cellular  composition of 
reactions  in a responder animal immunized with CFA was that of  a classical 
delayed hypersensitivity  reaction.  The  total  cellularity  was  much higher  than  in 
CBH, with  mononuclear  cell  predominating  and  relatively  few  basophils.  Practi- 
cally no cellular  response was elicited  under the same conditions  in nonre- 
sponder  animals, the  existing  mononuclear cellularity  representing  background 
levels. 
Discussion 
The results  in  this  paper  indicate  that  CBH to  DNP-GL, as  well  as  subsequent 
DH to noncross-reacting  DNP-PLL, can only be obtained in guinea pigs  which 
possess  the genetic  ability  to  respond to  these  antigens.  None of  these  delayed- 
in-onset  reactions  could be obtained in nonresponder animals. 
The reactions  observed in responder guinea pigs  were grossly  and histologi- 
cally  typical  for  either  type of  cell-mediated  reaction,  with  the exception  of  one 
animal labeled  responder by the supplier  which was on further  testing  deter- 
mined to  be  a nonresponder, since  it  failed  to  give  a positive  DH to  the  antigen it 
was selected  for. 
These results  provide further evidence that CBH  is dependent on and me- 
diated  by  T cells,  since  the  defect  of  nonresponder  guinea  pigs  in  the  PLL system 
seems to be manifested in their  T and not B cells  (13). 
Although it  seems likely  that  the  ability  to  develop DH and CBH to  synthetic 
polymers is  under the same genetic  control  and mediated by sensitized  T cells, 
these  experiments in  fact  do  not  suggest whether  they  depend on  a single  T cell, 
possibly  triggered  in different  ways, or on two distinct  T-cell  subpopulations, 
both  of  which exhibit  the  phenotypic expression  of  the  genetic  immune response 
status. 
Summary 
CBH to DNP-GL could be elicited only in responder guinea pigs which possess 
the  genetic ability to develop classic  delayed type hypersensitivity to  DNP- 
PLL, the response to which is governed by the same gene. Since the defect in 
nonresponder animals seems to reside at the level of  their T cells and not B cells, 
these  results  lend  support  to  the  contention that  CBH,  as  well  as  DH,  is 
dependent on and probably mediated by T cells. 
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